LOC105374736 (Gene)

Description:uncharacterized LOC105374736

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View LOC105374736's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with LOC105374736.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using LOC105374736.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for LOC105374736.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with LOC105374736.

Results found

Linked to

	Label	Description
	GSE213845 EZH2 inhibition 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE190937 AHCY MAT2A knockout Rael 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE183606 rutaecarpine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115328 lenalidomide 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 2 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE213845 EZH2 inhibition 4 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE190937 AHCY MAT2A knockout Rael 2 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE183606 rutaecarpine 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE216043 cisplatin 3 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE115328 lenalidomide 6 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 2 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.